Arcadia Biosciences Inc (17D.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
At close: 08:02AM CEST
| Previous Close | 2.6400 |
| Open | 2.5000 |
| Bid | 2.3200 x N/A |
| Ask | 2.5200 x N/A |
| Day's Range | 2.5000 - 2.5000 |
| 52 Week Range | 1.7200 - 4.2200 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZacksArcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Business WireArcadia Biosciences (RKDA) Announces Leadership Transition
DALLAS, July 09, 2024--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company and been replaced by Thomas J. Schaefer, effective July 5, 2024. Schaefer was previously Arcadia’s chief financial officer and will be replaced in that role by Mark Kawakami, Arcadia’s current vice president of finance.
ZacksArcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.
© 2024 Yahoo. All rights reserved.